Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Base4 Biotechnology discovers and develops RNA-targeted small-molecule therapeutics to treat diseases previously considered undruggable. The company combines atomic-scale biochemistry, quantum…

Base4 Biotechnology discovers and develops RNA-targeted small-molecule therapeutics to treat diseases previously considered undruggable. The company combines atomic-scale biochemistry, quantum…
Core focus: Structure-based discovery of RNA-targeting small-molecule therapeutics
Platform: VERITAS — AI-enhanced, quantum biophysical structure-based discovery
Founded: 2009 (originally named Nymirum)
Therapeutic areas: Neurology, oncology, neuromuscular and rare diseases
Reported investors: Orchard Venture Partners; Hopen Life Science Ventures
Therapeutics for diseases with RNA targets across neurology, oncology, neuromuscular and rare diseases.
2009
Biotechnology
3890000
Historic/obfuscated funding entry recorded with date Jan 1, 2010
“Orchard Venture Partners; Hopen Life Science Ventures”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week